Related references
Note: Only part of the references are listed.Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer
Hironori Ishigami et al.
ONCOLOGY (2009)
Chemotherapy for metastatic disease: review from JCOG trials
Narikazu Boku
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer
Hiroyuki Narahara et al.
ONCOLOGY (2008)
Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer
Shigeyuki Tamura et al.
GASTRIC CANCER (2007)
A phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites
Sung Yong Oh et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer
E. Mochiki et al.
BRITISH JOURNAL OF CANCER (2006)
Disparities in gastric cancer chemotherapy between the East and West
Atsushi Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients
Michiya Kobayashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer
K Fujitani et al.
ONCOLOGY (2005)
Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the gastrointestinal oncology study group of the Japan clinical oncology group, JCOG 9603 trial
T Yamao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-fluorouracil
T Mori et al.
ONCOLOGY (2003)
Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
Y Yamada et al.
ANNALS OF ONCOLOGY (2001)
Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure
PH Sugarbaker et al.
ONCOLOGY (2000)
Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer
W Koizumi et al.
ONCOLOGY (2000)
Share Paper
